Persistence of ex vivo expanded tumour and pathogen specific T-cells after allogeneic stem cell transplant for myeloid malignancies (the INTACT study)

Affiliations

• ¹ Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
• ² Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.
• ³ Blood Transplant and Cell Therapies Program, Department of Haematology, Westmead Hospital, Westmead, NSW, Australia.
• ⁴ Research and Education Network, Western Sydney Area Health Service, Westmead, NSW, Australia.
• ⁵ School of Mathematics and Statistics, Faculty of Science, University of Sydney, Camperdown, NSW, Australia.
• ⁶ Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia.
• ⁷ Infection, Immunity and Inflammation Theme, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
• ⁸ Blood Transplant and Cell Therapies Unit, The Children's Hospital at Westmead, Westmead, NSW, Australia.
• ⁹ Blood Transplant and Cell Therapies Laboratory, Institute for Pathology and Medical Research, NSW Health Pathology, Westmead, NSW, Australia.
• ¹⁰ Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia. emily.blyth@sydney.edu.au.
• ¹¹ Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia. emily.blyth@sydney.edu.au.
• ¹² Blood Transplant and Cell Therapies Program, Department of Haematology, Westmead Hospital, Westmead, NSW, Australia. emily.blyth@sydney.edu.au.